- Home
- OIO vs ABOS Comparison
OIO vs ABOS Comparison
Compare OIO & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$2.69
Company Overview
Basic Information| Metric | OIO | ABOS |
|---|---|---|
| Founded | 1999 | 1996 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.7M | 165.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | OIO | ABOS |
|---|---|---|
| Price | $2.16 | $2.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 40.8K | ★ 645.0K |
| Earning Date | 05-01-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.50 | $1.10 |
| 52 Week High | $7.50 | $3.60 |
Technical Indicators
Market Signals| Indicator | OIO | ABOS |
|---|---|---|
| Relative Strength Index (RSI) | 55.47 | 61.16 |
| Support Level | $1.60 | $2.14 |
| Resistance Level | $7.50 | $2.73 |
| Average True Range (ATR) | 0.32 | 0.17 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 74.35 | 77.34 |
Price Performance
Historical Comparison OIO
ABOS
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.